Search

Displaying results 8591 - 8600 of 10000 in total
  1. Drug

    Naveglitazar

    go.drugbank.com/drugs/DB12662
    Investigational

    Naveglitazar has been used in trials studying the treatment of Diabetes Mellitus, Non-Insulin-Dependent.

  2. Drug

    PHA-793887

    go.drugbank.com/drugs/DB12686
    Investigational

    PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.

  3. Drug

    CRA-028129

    go.drugbank.com/drugs/DB05951
    Experimental

    CRA-028129 is cathepsin S inhibitor which is under investigation for the treatment of psoriasis.

  4. Drug

    Dapivirine

    go.drugbank.com/drugs/DB08639
    Investigational

    Dapivirine has been investigated for the prevention of HIV-1 Infections and Topical Penile Exposures.

  5. Drug

    Axelopran

    go.drugbank.com/drugs/DB12013
    Investigational

    Axelopran has been used in trials studying the treatment of OIC and Opioid-induced Constipation.

  6. Drug

    Balapiravir

    go.drugbank.com/drugs/DB12283
    Investigational

    Balapiravir has been used in trials studying the treatment of Dengue and Hepatitis C, Chronic.

  7. Drug

    Tamibarotene

    go.drugbank.com/drugs/DB04942
    Investigational

    Tamibarotene is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States.

  8. Drug

    LS11

    go.drugbank.com/drugs/DB05918
    Investigational

    It is used to treat many kinds of cancers.

  9. Drug

    XL820

    go.drugbank.com/drugs/DB05146
    Investigational

    The proteins that XL820 inhibit include platelet-derived growth factor receptor beta (PDGFR), mast/stem cell growth factor receptor KIT, vascular endothelial growth factor receptor 2, and platelet-derived … growth factor receptor alpha, clinically validated targets implicated in a variety of human cancers.

  10. Drug

    Budigalimab

    go.drugbank.com/drugs/DB16668
    Investigational

    With IV Modified FOLFIRINOX (Mffx) With or Without IV Budigalimab Compared to Mffx in Adult Participants With Untreated Pancreatic Cancer Metastasis). … Budigalimab is under investigation in clinical trial NCT04807972 (Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 Is Administered in Combination